Literature DB >> 15531238

Effect of body mass index on nonalcoholic fatty liver disease in patients undergoing minimally invasive bariatric surgery.

Constantine T Frantzides1, Mark A Carlson, Ronald E Moore, John G Zografakis, Atul K Madan, Susan Puumala, Ali Keshavarzian.   

Abstract

The risk factors for nonalcoholic fatty liver disease in patients undergoing bariatric surgery are under study. We wanted to determine the correlation between nonalcoholic fatty liver disease and patient factors such as obesity and liver function tests. A retrospective analysis was performed on 177 nonalcoholic morbidly obese patients who underwent laparoscopic Roux-en-Y gastric bypass with liver biopsy, to identify risk factors for nonalcoholic fatty liver disease. The histologic grade of liver disease was compared with preoperative body mass index, age, and liver function tests. Simple steatosis and steatohepatitis were present in 90% and 42% of patients, respectively. Elevated transaminase levels were an independent risk for liver disease. Body mass index and liver disease were not correlated with univariate analysis. Regression analysis performed on age, body mass index, and liver disease demonstrated that the risk for liver disease increased with body mass index in the younger (<35 years old) age group and decreased with body mass index in the older (>45 years old) age group. There was a high incidence of steatosis and steatohepatitis in these nonalcoholic bariatric patients, and elevated transaminase level was indicative of disease. Body mass index was a positive risk factor for liver disease in younger patients but a negative risk factor in the older patients.

Entities:  

Mesh:

Year:  2004        PMID: 15531238     DOI: 10.1016/j.gassur.2004.07.001

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  19 in total

Review 1.  Nonalcoholic steatohepatitis: what we know in the new millennium.

Authors:  Stephen A Harrison; Shailesh Kadakia; Kevin A Lang; Steven Schenker
Journal:  Am J Gastroenterol       Date:  2002-11       Impact factor: 10.864

2.  Liver fibrosis in overweight patients.

Authors:  V Ratziu; P Giral; F Charlotte; E Bruckert; V Thibault; I Theodorou; L Khalil; G Turpin; P Opolon; T Poynard
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

Review 3.  Complications after laparoscopic gastric bypass: a review of 3464 cases.

Authors:  Yale D Podnos; Juan C Jimenez; Samuel E Wilson; C Melinda Stevens; Ninh T Nguyen
Journal:  Arch Surg       Date:  2003-09

4.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

5.  Liver pathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery.

Authors:  Pierre M Gholam; Donald P Kotler; Louis J Flancbaum
Journal:  Obes Surg       Date:  2002-02       Impact factor: 4.129

Review 6.  Unsuspected cirrhosis discovered during elective obesity operations.

Authors:  R E Brolin; L J Bradley; R V Taliwal
Journal:  Arch Surg       Date:  1998-01

7.  Hepatic steatosis in patients undergoing bariatric surgery and its relationship to body mass index and co-morbidities.

Authors:  Myriam Moretto; Carlos Kupski; Cláudio Corá Mottin; Giuseppe Repetto; Marcelo Garcia Toneto; Jacqueline Rizzolli; Diovanne Berleze; Cesar Luis de Souza Brito; Daniela Casagrande; Fernanda Colossi
Journal:  Obes Surg       Date:  2003-08       Impact factor: 4.129

8.  Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery.

Authors:  Charles Beymer; Kris V Kowdley; Anne Larson; Paul Edmonson; E Patchen Dellinger; David R Flum
Journal:  Arch Surg       Date:  2003-11

9.  Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

Authors:  J Ludwig; T R Viggiano; D B McGill; B J Oh
Journal:  Mayo Clin Proc       Date:  1980-07       Impact factor: 7.616

10.  The natural history of nonalcoholic fatty liver: a follow-up study.

Authors:  M R Teli; O F James; A D Burt; M K Bennett; C P Day
Journal:  Hepatology       Date:  1995-12       Impact factor: 17.425

View more
  17 in total

1.  Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.

Authors:  Palanivelu Praveenraj; Rachel M Gomes; Saravana Kumar; Purushothaman Karthikeyan; Annapoorni Shankar; Ramakrishnan Parthasarathi; Palanisamy Senthilnathan; Subbiah Rajapandian; Chinnusamy Palanivelu
Journal:  Obes Surg       Date:  2015-11       Impact factor: 4.129

Review 2.  The effect of bariatric surgeries on nonalcoholic fatty liver disease.

Authors:  Mazen Hassanian; Amnah Al-Mulhim; Atheer Al-Sabhan; Shaden Al-Amro; Fahad Bamehriz; Ayman Abdo; Hisham Al Khalidi; Tamader A Aldoheyan
Journal:  Saudi J Gastroenterol       Date:  2014 Sep-Oct       Impact factor: 2.485

3.  The effects of bariatric surgeries on nonalcoholic fatty liver disease.

Authors:  Tamadar Aldoheyan; Mazen Hassanain; Amnah Al-Mulhim; Atheer Al-Sabhan; Shaden Al-Amro; Fahad Bamehriz; Hisham Al-Khalidi
Journal:  Surg Endosc       Date:  2016-07-12       Impact factor: 4.584

4.  Bariatric surgery-induced weight loss reduces hepatic lipid peroxidation levels and affects hepatic cytochrome P-450 protein content.

Authors:  Lauren N Bell; Constance J Temm; Rashmil Saxena; Raj Vuppalanchi; Philip Schauer; Mordechai Rabinovitz; Alyssa Krasinskas; Naga Chalasani; Samer G Mattar
Journal:  Ann Surg       Date:  2010-06       Impact factor: 12.969

5.  Evolution of Liver Steatosis Quantified by MR Imaging and MR Spectroscopy, in Morbidly Obese Patients Undergoing Sleeve Gastrectomy: Short-Term Outcomes.

Authors:  María Engracia Alsina; Jaime Ruiz-Tovar; Angela Bernabeu
Journal:  Obes Surg       Date:  2017-07       Impact factor: 4.129

6.  Comparison of laparoscopic sleeve gastrectomy and laparoscopic gastric plication: One year follow-up results.

Authors:  Şükrü Salih Toprak; Yücel Gültekin; Ahmet Okuş
Journal:  Ulus Cerrahi Derg       Date:  2015-08-18

7.  Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome.

Authors:  Samer G Mattar; Laura M Velcu; Mordechai Rabinovitz; A J Demetris; A M Krasinskas; Emma Barinas-Mitchell; George M Eid; Ramesh Ramanathan; Debra S Taylor; Philip R Schauer
Journal:  Ann Surg       Date:  2005-10       Impact factor: 12.969

8.  Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity.

Authors:  Theodore K Alexandrides; George Skroubis; Fotis Kalfarentzos
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

9.  The incapacity of the surgeon to identify NASH in bariatric surgery makes biopsy mandatory.

Authors:  Antônio Roberto Franchi Teixeira; Marta Bellodi-Privato; José Barreto Carvalheira; Victor Fernando Pilla; José Carlos Pareja; Luiz Augusto Carneiro D'Albuquerque
Journal:  Obes Surg       Date:  2009-12       Impact factor: 4.129

Review 10.  Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status.

Authors:  Lance L Stein; Mamie H Dong; Rohit Loomba
Journal:  Adv Ther       Date:  2009-11-16       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.